Search

Your search keyword '"T. Santhosh"' showing total 235 results

Search Constraints

Start Over You searched for: Author "T. Santhosh" Remove constraint Author: "T. Santhosh"
235 results on '"T. Santhosh"'

Search Results

201. Molecular probes for the A2A adenosine receptor based on a pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine scaffold

202. Synthesis and evaluation of 1,2,4-triazolo[1,5-c]pyrimidine derivatives as A2A receptor-selective antagonists

203. Novel Alexa Fluor-488 labeled antagonist of the A2A adenosine receptor: Application to a fluorescence polarization-based receptor binding assay

204. Functionalized 2'-Amino-α-L-LNA: Directed Positioning of Intercalators for DNA Targeting.

205. Dental caries experience and treatment needs of green marble mine laborers in Udaipur district, Rajasthan, India.

208. Dopamine D2 receptor-mediated modulation of adenosine A2A receptor agonist binding within the A2AR/D2R oligomer framework

211. Perturbing chondroitin sulfate proteoglycan signaling through LAR and PTPσ receptors promotes a beneficial inflammatory response following spinal cord injury

212. Neuregulin-1 elicits a regulatory immune response following traumatic spinal cord injury

213. Are WHO approved nucleic acid amplification tests causing large-scale 'false identification' of rifampicin-resistant tuberculosis?: Programmatic experience from south india

214. High moxifloxacin cross-resistance levels among 'newly identified' ofloxacin-resistant multidrug-resistant tuberculosis patients from South India: A ticking bomb or a tricky challenge?

216. Dopamine D2 receptor-mediated modulation of adenosine A2A receptor agonist binding within the A2AR/D2R oligomer framework.

217. Cardiovascular complications during pregnancy: Advancing cardio-obstetrics.

218. A Case Report of Auditory and Vestibular Findings in a Patient with Rheumatoid Arthritis and Diabetes Mellitus.

219. Lipid Trolling to Optimize A 3 Adenosine Receptor-Positive Allosteric Modulators (PAMs).

220. The Obesity Paradox in Chronic Heart Disease and Chronic Obstructive Pulmonary Disease.

221. Exploring the growth of COVID-19 cases using exponential modelling across 42 countries and predicting signs of early containment using machine learning.

222. Systematic literature review on novel corona virus SARS-CoV-2: a threat to human era.

223. Branched DNA nanostructures efficiently stabilised and monitored by novel pyrene-perylene 2'-α-L-amino-LNA FRET pairs.

224. Virtual screening leads to the discovery of novel non-nucleotide P2Y₁ receptor antagonists.

225. Synthesis and P2Y₂ receptor agonist activities of uridine 5'-phosphonate analogues.

226. Evaluation of molecular modeling of agonist binding in light of the crystallographic structure of an agonist-bound A₂A adenosine receptor.

227. Structure-activity relationship of (N)-Methanocarba phosphonate analogues of 5'-AMP as cardioprotective agents acting through a cardiac P2X receptor.

228. C5-functionalized LNA: unparalleled hybridization properties and enzymatic stability.

229. Risk factors for epilepsy: a population-based case-control study in Kerala, southern India.

230. Oral health status and practices of dentate Bhil adult tribes of southern Rajasthan, India.

231. 2'-N-(pyren-1-yl)acetyl-2'-amino-alpha-L-LNA: synthesis and detection of single nucleotide mismatches in DNA and RNA targets.

232. Synthesis and biophysical studies of N2'-functionalized 2'-amino-alpha-L-LNA.

233. Pyrene-functionalized 2'-amino-alpha-L-LNA as potential diagnostic probes.

234. Targeting of mixed sequence double-stranded DNA using pyrene-functionalized 2'-amino-alpha-l-LNA.

235. Synthesis of a 2'-amino-alpha-1-LNA-T phosphoramidite.

Catalog

Books, media, physical & digital resources